世茂股份(600823.SH)股東世茂投資增持1686.3萬股 擬繼續增持不超5%股份
格隆匯12月25日丨世茂股份(600823.SH)公佈,2019年12月25日,公司第三大股東上海世茂投資管理有限公司通過上海證券交易所集中競價交易系統增持本公司股票1686.3萬股,佔公司總股本的比例為0.45%。世茂投資計劃在本次增持之日起6個月內繼續增持,擬累計增持比例不低於公司總股本的0.45%,不超過公司總股本的5%(含本次增持)。
本次增持計劃未設定價格區間,世茂投資將基於對公司股票價值的合理判斷,並根據公司股票價格波動情況及資本市場整體趨勢,逐步實施增持計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.